Veterinary Medicines

Advantix Dog 40/200 100 mg/ml - 500 mg/ml Spot-on oplossing

Authorised
  • Imidacloprid
  • Permethrin
Download as PDF

Product identification

Medicine name:
Advantix Dog 40/200 100 mg/ml - 500 mg/ml Spot-on oplossing
Advantix Dog 40/200 100 mg/ml - 500 mg/ml Solution pour spot-on
Advantix Dog 40/200 100 mg/ml - 500 mg/ml Lösung zum Auftropfen
Active substance:
  • Imidacloprid
  • Permethrin
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
  • Permethrin
    200.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Advantix Dog 40/200 24 Pipettes with 0.4 ml Spot-on solution
  • Advantix Dog 40/200 6 Pipettes with 0.4 ml Spot-on solution
  • Advantix Dog 40/200 4 Pipettes with 0.4 ml Spot-on solution
  • Advantix Dog 40/200 3 Pipettes with 0.4 ml Spot-on solution
  • Advantix Dog 40/200 2 Pipettes with 0.4 ml Spot-on solution
  • Advantix Dog 40/200 1 Pipette with 0.4 ml Spot-on solution

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed Consent application (Article 21 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V459742
Date of authorisation status change:
Informed consent reference:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 16/02/2023
Download
French (PDF)
Published on: 16/02/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/02/2023
Download
French (PDF)
Published on: 17/02/2023
Download
German (PDF)
Published on: 17/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."